SEC Company Response from BiomX Inc. (PHGE) (CIK 0001739174) (HLSQ) — Dec 12, 2018
BiomX Inc. (PHGE) (CIK 0001739174)
Date: Dec. 12, 2018 · CIK: 0001739174 · Accession: 0001615774-18-014307
AI Filing Summary & Sentiment
File numbers found in text: 333-228533
Show Raw Text
CORRESP
1
filename1.htm
Chardan
Healthcare Acquisition Corp.
17 State Street, Fl 21
New York, NY 10004
December
12, 2018
VIA
EDGAR & TELECOPY
Edward M. Kelly
Division of Corporation Finance Office of
Manufacturing
and Construction
U.S. Securities & Exchange Commission
100
F Street, NE
Washington,
D.C. 20549
RE:
Chardan Healthcare Acquisition Corp. (the
“Company”)
Registration Statement on Form S-1
(File
No. 333-228533) (the “Registration Statement”)
Dear
Mr. Kelly:
The
Company hereby requests, pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, acceleration of effectiveness
of the Registration Statement so that such Registration Statement will become effective as of 4:00 p.m. on December 13, 2018,
or as soon thereafter as practicable.
The
Company hereby acknowledges that:
● Should
the Securities and Exchange Commission (the “Commission”) or the Staff, acting
pursuant to delegated authority, declare the Registration Statement effective, it does
not foreclose the Commission from taking any action with respect to the Registration
Statement;
● The
action of the Commission or the Staff, acting pursuant to delegated authority, in declaring
the Registration Statement effective, does not relieve the Company from its full responsibility
for the adequacy and accuracy of the disclosure in the Registration Statement; and
● The
Company may not assert Staff comments and the declaration of effectiveness as a defense
in any proceeding initiated by the Commission or any person under the federal securities
laws of the United States.
[Signature
page follows]
Very truly yours,
CHARDAN HEALTHCARE ACQUISITION
CORP
By:
/s/
Jonas Grossman
Name: Jonas Grossman
Title: President
Acceleration Request:
333-228533